Rennova Health, Inc. (NASDAQ: RNVA), based in West Palm Beach, Florida, specializes in providing a full range of medical and administrative technologies and services to U.S. healthcare providers. The company’s suite of products and services are designed to enhance treatment success while streamlining customer and financial information processing, improving both patient and financial outcomes.
Rennova Health provider solutions include:
- Diagnostic Solutions – Rennova offers comprehensive clinical testing services, including advanced toxicology and esoteric lab services such as urine testing for abuse of drugs and prescription medications, in addition to bacteriology, serology, immunology, hematology and neurotransmitter testing.
Brands: Medytox Diagnostics
- Revenue Cycle Management – Rennova’s sophisticated medical billing solution, centered around the customer, is structured to ensure a billing process that is highly efficient, reducing errors and producing more accurate claims, resulting in faster reimbursement and maximizing provider cash flow.
Brands: Medical Billing Choices - Healthcare Technology Solutions – Rennova software applications provide advanced processing for both electronic health records (EHRs) and laboratory information management system records, and include web-based technology for managing diagnostic lab testing orders and reports.
Brands: ClinLab Advanced Medical Software, Medical Mime, Advantage, CollabRx - Financial Services – Rennova also offers direct financial services to help providers better deal with customer payment lag to encourage positive cash flow, including specialized loans that convert outstanding accounts receivable assets into working capital.
Brands: Platinum Financial Solutions
Rennova Health’s market strength rests on its ability to enhance both the speed and accuracy of diagnostic testing and record processing for healthcare providers, with a growing offering of integrated brands.
For more information, visit www.RennovaHealth.com
